Gregor S Reiter Selected Research

Macular Degeneration (Age-Related Maculopathy)

2/2024	Structure-Function Correlation of Retinal Fibrosis in Eyes with Neovascular Age-Related Macular Degeneration.
12/2023	Point-to-point associations of drusen and hyperreflective foci volumes with retinal sensitivity in non-exudative age-related macular degeneration.
11/2023	Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration: results from Fight Retinal Blindness!
9/2023	Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine (FRB!).
6/2023	Deep survival modeling of longitudinal retinal OCT volumes for predicting the onset of atrophy in patients with intermediate AMD.
2/2023	Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning.
1/2023	Predicting Topographic Disease Progression and Treatment Response of Pegcetacoplan in Geographic Atrophy Quantified by Deep Learning.
1/2023	Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis.
1/2023	Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)-a phase III, prospective, multicentre, randomized study: design and methods.
1/2023	Progression Dynamics of Early versus Later Stage Atrophic Lesions in Nonneovascular Age-Related Macular Degeneration Using Quantitative OCT Biomarker Segmentation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregor S Reiter Research Topics

Disease

16	Macular Degeneration (Age-Related Maculopathy) 02/2024 - 03/2021
7	Geographic Atrophy 01/2024 - 10/2022
4	Atrophy 11/2023 - 12/2022
3	Cataract (Cataracts) 03/2024 - 01/2021
2	Disease Progression 04/2024 - 01/2023
2	Fibrosis (Cirrhosis) 02/2024 - 11/2023
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2024 - 01/2022
2	Blindness (Hysterical Blindness) 11/2023 - 09/2023
1	Retinal Diseases 01/2022
1	Choroidal Neovascularization 03/2021

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 03/2024 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 03/2021
3	pegcetacoplanIBA 01/2023 - 11/2022
2	afliberceptIBA 01/2023 - 03/2021
1	7,14-dihydroxypregn-4-ene-3,20-dioneIBA 01/2024
1	Endothelial Growth FactorsIBA 09/2023
1	Retinal Pigments (Pigments, Visual)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	brolucizumabIBA 01/2023
1	Therapeutic UsesIBA 11/2022
1	salicylhydroxamic acid (SHAM)IBA 11/2022

Therapy/Procedure

4	Therapeutics 09/2023 - 03/2021
3	Lasers (Laser) 03/2024 - 01/2021
1	Intravitreal Injections 01/2022
1	Precision Medicine 01/2022
1	Phacoemulsification 01/2021